PVLA
Palvella Therapeutics, Inc. has filed 774 documents with the SEC between 2013 and 2026. The most frequent type is major company event (208 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2025-12-15 | 2025-12-15 |
| Insider trade | 4 | 2025-11-21 | 2025-11-19 |
| Insider sale notice | 144 | 2025-11-19 | - |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G/A | - | 2025-11-13 | - |
| Quarterly report | 10-Q | 2025-11-12 | 2025-09-30 |
| Major company event | 8-K | 2025-11-10 | 2025-11-10 |
| Major company event | 8-K | 2025-11-05 | 2025-11-05 |
| Major company event | 8-K | 2025-09-24 | 2025-09-24 |
| Major company event | 8-K | 2025-09-03 | 2025-09-03 |
| SCHEDULE 13G/A | - | 2025-08-14 | - |
| SCHEDULE 13G/A | - | 2025-08-14 | - |
| Quarterly report | 10-Q | 2025-08-14 | 2025-06-30 |
| Major company event | 8-K | 2025-08-14 | 2025-08-14 |
| Insider trade | 4 | 2025-06-11 | 2025-06-10 |
| Insider trade | 4 | 2025-06-11 | 2025-06-10 |
| Insider trade | 4 | 2025-06-11 | 2025-06-10 |
| Insider trade | 4 | 2025-06-11 | 2025-06-10 |
| Insider trade | 4 | 2025-06-11 | 2025-06-10 |
| Major company event | 8-K | 2025-06-11 | 2025-06-10 |
| Insider trade | 4 | 2025-06-03 | 2025-05-27 |
| New insider ownership | 3 | 2025-06-03 | 2025-05-27 |
| SCHEDULE 13G/A | - | 2025-05-15 | - |
| Quarterly report | 10-Q | 2025-05-15 | 2025-03-31 |
| Major company event | 8-K | 2025-05-15 | 2025-05-15 |
| Annual report to shareholders | ARS | 2025-04-30 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-30 | - |
| Proxy statement | DEF 14A | 2025-04-30 | 2025-06-10 |
| Insider trade | 4 | 2025-04-10 | 2025-04-09 |
| Annual report | 10-K | 2025-03-31 | 2024-12-31 |
| Major company event | 8-K | 2025-03-31 | 2025-03-31 |
| Major company event | 8-K | 2025-03-04 | 2025-03-04 |
| Employee stock plan | S-8 | 2025-02-18 | - |
| Insider trade (amended) | 4/A | 2025-02-10 | 2025-02-05 |
| Insider trade (amended) | 4/A | 2025-02-10 | 2025-02-05 |
| Insider trade (amended) | 4/A | 2025-02-10 | 2025-02-05 |
| Insider trade (amended) | 4/A | 2025-02-10 | 2025-02-05 |
| Insider trade | 4 | 2025-02-07 | 2025-02-05 |
| Insider trade | 4 | 2025-02-07 | 2025-02-05 |
| Insider trade | 4 | 2025-02-07 | 2025-02-05 |
| Insider trade | 4 | 2025-02-07 | 2025-02-05 |
| 424B3 | - | 2025-01-17 | - |
| EFFECT | - | 2025-01-16 | - |
| Company correspondence | CORRESP | 2025-01-15 | - |
| S-1/A | - | 2025-01-14 | - |
| Major company event | 8-K | 2025-01-13 | 2025-01-13 |
| SCHEDULE 13G | - | 2025-01-08 | - |
| 3/A | - | 2025-01-06 | 2024-12-13 |
| SEC correspondence | UPLOAD | 2025-01-03 | - |
| IPO registration | S-1 | 2024-12-31 | - |